» Articles » PMID: 9059708

Neuropsychological Function in Patients with Increased Serum Levels of Protein S-100 After Minor Head Injury

Overview
Specialty Neurosurgery
Date 1997 Jan 1
PMID 9059708
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Protein S-100 is a calcium binding protein, synthetized in astroglial cells in all parts of the central nervous system (CNS). We have previously reported high serum levels of protein S-100 in patients after minor head injury (MHI). A battery of conventional and computerized neuropsychological measures was administered to two groups of MHI patients. Neuropsychological outcome at 12 months postinjury was examined in a group of 7 patients with increased serum levels of protein S-100 after MHI and 7 age- and sex-matched controls without detectable S-100 in serum after MHI. Our results demonstrate no overall cognitive dysfunction in either of the two groups. Our findings indicate specific dysfunction on measures of reaction time, attention and speed of information processing for the S-100 group. Posttraumatic depression does not explain the neuropsychological differences between the groups. These findings support that increased serum levels of protein S-100 may be of predictive and prognostic value for longlasting neurocognitive abnormalities after minor head injury. Presence of S-100 in serum may indicate the presence of diffuse brain damage. Our results suggest that information processing measures in computerized neuropsychological assessment are more sensitive for detecting small signs of neurocognitive abnormalities after MHI than conventional test batteries.

Citing Articles

Prediction of Neurocognitive Outcome after Moderate-Severe Traumatic Brain Injury Using Serum Neuron-Specific Enolase and S100 biomarkers.

Slavoaca D, Birle C, Stan A, Tatomir A, Popa O, Rosu P J Med Life. 2020; 13(3):306-313.

PMID: 33072201 PMC: 7550145. DOI: 10.25122/jml-2020-0147.


Characterizing the Risk of Depression Following Mild Traumatic Brain Injury: A Meta-Analysis of the Literature Comparing Chronic mTBI to Non-mTBI Populations.

Hellewell S, Beaton C, Welton T, Grieve S Front Neurol. 2020; 11:350.

PMID: 32508733 PMC: 7248359. DOI: 10.3389/fneur.2020.00350.


Review of the potential use of blood neuro-biomarkers in the diagnosis of mild traumatic brain injury.

Jones A, Jarvis P Clin Exp Emerg Med. 2017; 4(3):121-127.

PMID: 29026884 PMC: 5635461. DOI: 10.15441/ceem.17.226.


Characteristics of patients included and enrolled in studies on the prognostic value of serum biomarkers for prediction of postconcussion symptoms following a mild traumatic brain injury: a systematic review.

Mercier E, Tardif P, Emond M, Ouellet M, de Guise E, Mitra B BMJ Open. 2017; 7(9):e017848.

PMID: 28963310 PMC: 5623519. DOI: 10.1136/bmjopen-2017-017848.


Biochemical changes in the injured brain.

Sahu S, Nag D, Swain A, Samaddar D World J Biol Chem. 2017; 8(1):21-31.

PMID: 28289516 PMC: 5329711. DOI: 10.4331/wjbc.v8.i1.21.